Clinical Trials Directory

Trials / Completed

CompletedNCT06594406

The Effect of Oral Bifidobacterium on Exogenous Creatine Absorption in Adult Subjects

The Therapeutic Effects of Combining Bifidobacterium With Creatine on Depression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
77 (actual)
Sponsor
Zhujiang Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this clinical trial is to learn if Bifidobacterium has antidepressant-like effects by enhancing creatine absorption in adults. The main questions to be answered are Does Bifidobacterium combined with creatine have better antidepressant effects? Does Bifidobacterium enhance exogenous creatine uptake? Researchers will compare bifidobacterium combined with creatine with placebo to see if bifidobacterium combined with creatine has antidepressant effects. Participants will: Take bifidobacterium, creatine or placebo every day for 4 weeks. Keep a diary of their symptoms and collect blood samples.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCreatineThe dosing schedule of creatine administration is 3 g daily for 4 weeks, and administration of a placebo.
DIETARY_SUPPLEMENTBifidobacterium and creatineThe dosing schedule of creatine administration is 3 g daily for 4 weeks. In parallel, the dosing schedule of bifidobacterium administration is 200 million colony-forming units (CFU) /day for 4 weeks.
DIETARY_SUPPLEMENTPlaceboAdministration of creatine placebo and bifidobacterium placebo for 4 weeks,

Timeline

Start date
2024-10-10
Primary completion
2025-05-30
Completion
2025-06-27
First posted
2024-09-19
Last updated
2025-08-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06594406. Inclusion in this directory is not an endorsement.